ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.

Olga Salamero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.